MedTrace Logo

Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty

NCT02829346 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-07-12

No results posted yet for this study

Summary

This study evaluates the peri-articular tranexamic acid injection in total knee arthroplasty which is an alternative route of administration for blood loss reduction. Half of participants will receive intravenous tranexamic acid injection, while the other half will receive peri-articular tranexamic acid injection during total knee arthroplasty.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Peri-articular tranexamic acid

750 mg of peri-articular TXA, prior to deflating the tourniquet and wound closure

DRUG

Intravenous tranexamic acid

750 mg of IV TXA, prior to deflating the tourniquet and wound closure

Sponsors & Collaborators

  • Thammasat University

    lead OTHER

Principal Investigators

  • Piya Pinsornsak, MD · Faculty of Medicine, Thammasat university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02829346 on ClinicalTrials.gov